Donor Serostatus Has an Impact on Cytomegalovirus-Specific Immunity, Cytomegaloviral Disease Incidence, and Survival in Seropositive Hematopoietic Cell Transplant Recipients (Q44554036)

From Wikidata

Jump to navigation Jump to search

scientific article published on August 3, 2010

Language	Label	Description	Also known as
English	Donor Serostatus Has an Impact on Cytomegalovirus-Specific Immunity, Cytomegaloviral Disease Incidence, and Survival in Seropositive Hematopoietic Cell Transplant Recipients	scientific article published on August 3, 2010

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Donor serostatus has an impact on cytomegalovirus-specific immunity, cytomegaloviral disease incidence, and survival in seropositive hematopoietic cell transplant recipients (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Donor Serostatus Has an Impact on Cytomegalovirus-Specific Immunity, Cytomegaloviral Disease Incidence, and Survival in Seropositive Hematopoietic Cell Transplant Recipients (English)

1 reference

10.1016/J.BBMT.2010.07.020

https://api.crossref.org/works/10.1016/J.BBMT.2010.07.020

17 June 2024

Cytomegalovirus

0 references

cytomegaloviral disease

1 reference

based on heuristic

inferred from title

Tyler Williamson

5

object named as

Tyler S. Williamson

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20688181

17 June 2024

8

object named as

Lina Roa

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20688181

17 June 2024

author name string

Alejandra Ugarte-Torres

1

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Mette Hoegh-Petersen

2

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Yiping Liu

3

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Feng Zhou

4

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Diana Quinlan

6

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Sarah Sy

7

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Faisal Khan

9

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Kevin Fonseca

10

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Jan Storek

12

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

James A. Russell

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20688181

17 June 2024

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20688181

17 June 2024

publication date

3 August 2010

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

full work available at URL

http://www.bbmt.org/article/S1083879110003216/pdf

Portable Document Format

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20688181

17 June 2024

https://api.elsevier.com/content/article/PII:S1083879110003216?httpAccept=text/xml

1 reference

10.1016/J.BBMT.2010.07.020

https://api.crossref.org/works/10.1016/J.BBMT.2010.07.020

17 June 2024

https://api.elsevier.com/content/article/PII:S1083879110003216?httpAccept=text/plain

1 reference

10.1016/J.BBMT.2010.07.020

https://api.crossref.org/works/10.1016/J.BBMT.2010.07.020

17 June 2024

Biology of Blood and Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

17

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

574-585

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Prolonged immune deficiency following allogeneic stem cell transplantation: risk factors and complications in adult patients

1

1 reference

10.1016/J.BBMT.2010.07.020

https://api.crossref.org/works/10.1016/J.BBMT.2010.07.020

17 June 2024

Cytomegalovirus in hematopoietic stem cell transplant recipients: current status, known challenges, and future strategies

2

1 reference

10.1016/J.BBMT.2010.07.020

https://api.crossref.org/works/10.1016/J.BBMT.2010.07.020

17 June 2024

Lymphocyte responses after cytomegalovirus infection in bone marrow transplant recipients--a one-year follow-up

5

1 reference

10.1016/J.BBMT.2010.07.020

https://api.crossref.org/works/10.1016/J.BBMT.2010.07.020

17 June 2024

Monitoring cytomegalovirus IE-1 and pp65-specific CD4+ and CD8+ T-cell responses after allogeneic stem cell transplantation may identify patients at risk for recurrent CMV reactivations

7

1 reference

10.1016/J.BBMT.2010.07.020

https://api.crossref.org/works/10.1016/J.BBMT.2010.07.020

17 June 2024

Cytomegalovirus-specific CD4+ and CD8+ T-cells follow a similar reconstitution pattern after allogeneic stem cell transplantation

8

1 reference

10.1016/J.BBMT.2010.07.020

https://api.crossref.org/works/10.1016/J.BBMT.2010.07.020

17 June 2024

Immune reconstitution to cytomegalovirus after allogeneic hematopoietic stem cell transplantation: impact of host factors, drug therapy, and subclinical reactivation

10

1 reference

10.1016/J.BBMT.2010.07.020

https://api.crossref.org/works/10.1016/J.BBMT.2010.07.020

17 June 2024

Early reconstitution of effector memory CD4+ CMV-specific T cells protects against CMV reactivation following allogeneic SCT.

11

1 reference

10.1016/J.BBMT.2010.07.020

https://api.crossref.org/works/10.1016/J.BBMT.2010.07.020

17 June 2024

Evidence for transfer of cellular and humoral immunity to cytomegalovirus from donor to recipient in allogeneic bone marrow transplantation

12

1 reference

10.1016/J.BBMT.2010.07.020

https://api.crossref.org/works/10.1016/J.BBMT.2010.07.020

17 June 2024

Evaluation of intervention strategy based on CMV-specific immune responses after allogeneic SCT.

13

1 reference

10.1016/J.BBMT.2010.07.020

https://api.crossref.org/works/10.1016/J.BBMT.2010.07.020

17 June 2024

Risk factors for the development of cytomegalovirus disease after allogeneic stem cell transplantation

14

1 reference

10.1016/J.BBMT.2010.07.020

https://api.crossref.org/works/10.1016/J.BBMT.2010.07.020

17 June 2024

Risk factors associated with late cytomegalovirus reactivation after allogeneic stem cell transplantation for hematological malignancies

15

1 reference

10.1016/J.BBMT.2010.07.020

https://api.crossref.org/works/10.1016/J.BBMT.2010.07.020

17 June 2024

Cytomegalovirus reactivation in pediatric hemopoietic progenitors transplant: a retrospective study on the risk factors and the efficacy of treatment

16

1 reference

10.1016/J.BBMT.2010.07.020

https://api.crossref.org/works/10.1016/J.BBMT.2010.07.020

17 June 2024

Impact of donor CMV status on viral infection and reconstitution of multifunction CMV-specific T cells in CMV-positive transplant recipients

17

1 reference

10.1016/J.BBMT.2010.07.020

https://api.crossref.org/works/10.1016/J.BBMT.2010.07.020

17 June 2024

High risk of death due to bacterial and fungal infection among cytomegalovirus (CMV)-seronegative recipients of stem cell transplants from seropositive donors: evidence for indirect effects of primary CMV infection

18

1 reference

10.1016/J.BBMT.2010.07.020

https://api.crossref.org/works/10.1016/J.BBMT.2010.07.020

17 June 2024

Donor CMV serologic status and outcome of CMV-seropositive recipients after unrelated donor stem cell transplantation: an EBMT megafile analysis

19

1 reference

10.1016/J.BBMT.2010.07.020

https://api.crossref.org/works/10.1016/J.BBMT.2010.07.020

17 June 2024

Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age

20

1 reference

10.1016/J.BBMT.2010.07.020

https://api.crossref.org/works/10.1016/J.BBMT.2010.07.020

17 June 2024

Stem cell transplantation for chronic myeloid leukemia in children

21

1 reference

10.1016/J.BBMT.2010.07.020

https://api.crossref.org/works/10.1016/J.BBMT.2010.07.020

17 June 2024

Late diversification in the clonal composition of human cytomegalovirus-specific CD8+ T cells following allogeneic hemopoietic stem cell transplantation

22

1 reference

10.1016/J.BBMT.2010.07.020

https://api.crossref.org/works/10.1016/J.BBMT.2010.07.020

17 June 2024

Pretransplantation CMV-specific T cells protect recipients of T-cell-depleted grafts against CMV-related complications

23

1 reference

10.1016/J.BBMT.2010.07.020

https://api.crossref.org/works/10.1016/J.BBMT.2010.07.020

17 June 2024

Immune reconstitution following reduced-intensity transplantation with cladribine, busulfan, and antithymocyte globulin: serial comparison with conventional myeloablative transplantation

24

1 reference

10.1016/J.BBMT.2010.07.020

https://api.crossref.org/works/10.1016/J.BBMT.2010.07.020

17 June 2024

A prospective analysis of immune recovery in children following allogeneic transplantation of t-cell-depleted or non-T-cell-depleted hematopoietic cells from HLA-disparate family donors

25

1 reference

10.1016/J.BBMT.2010.07.020

https://api.crossref.org/works/10.1016/J.BBMT.2010.07.020

17 June 2024

Effect of antithymocyte globulin on quantitative immune recovery and graft-versus-host disease after partially T-cell-depleted bone marrow transplantation: a comparison between recipients of matched related and matched unrelated donor grafts.

26

1 reference

10.1016/J.BBMT.2010.07.020

https://api.crossref.org/works/10.1016/J.BBMT.2010.07.020

17 June 2024

Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO).

27

1 reference

10.1016/J.BBMT.2010.07.020

https://api.crossref.org/works/10.1016/J.BBMT.2010.07.020

17 June 2024

Adult recipients of matched related donor blood cell transplants given myeloablative regimens including pretransplant antithymocyte globulin have lower mortality related to graft-versus-host disease: a matched pair analysis

28

1 reference

10.1016/J.BBMT.2010.07.020

https://api.crossref.org/works/10.1016/J.BBMT.2010.07.020

17 June 2024

Transplantation from matched siblings using once-daily intravenous busulfan/fludarabine with thymoglobulin: a myeloablative regimen with low nonrelapse mortality in all but older patients with high-risk disease

29

1 reference

10.1016/J.BBMT.2010.07.020

https://api.crossref.org/works/10.1016/J.BBMT.2010.07.020

17 June 2024

1994 Consensus Conference on Acute GVHD Grading

30

1 reference

10.1016/J.BBMT.2010.07.020

https://api.crossref.org/works/10.1016/J.BBMT.2010.07.020

17 June 2024

Human cytomegalovirus infection of the major leukocyte subpopulations and evidence for initial viral replication in polymorphonuclear leukocytes from viremic patients

31

1 reference

10.1016/J.BBMT.2010.07.020

https://api.crossref.org/works/10.1016/J.BBMT.2010.07.020

17 June 2024

Comparison of LightCycler-based PCR, COBAS amplicor CMV monitor, and pp65 antigenemia assays for quantitative measurement of cytomegalovirus viral load in peripheral blood specimens from patients after solid organ transplantation

32

1 reference

10.1016/J.BBMT.2010.07.020

https://api.crossref.org/works/10.1016/J.BBMT.2010.07.020

17 June 2024

Definitions of cytomegalovirus infection and disease in transplant recipients

33

1 reference

10.1016/J.BBMT.2010.07.020

https://api.crossref.org/works/10.1016/J.BBMT.2010.07.020

17 June 2024

Multiple-cytokine-producing antiviral CD4 T cells are functionally superior to single-cytokine-producing cells

34

1 reference

10.1016/J.BBMT.2010.07.020

https://api.crossref.org/works/10.1016/J.BBMT.2010.07.020

17 June 2024

Polyfunctional T cell responses are a hallmark of HIV-2 infection

35

1 reference

10.1016/J.BBMT.2010.07.020

https://api.crossref.org/works/10.1016/J.BBMT.2010.07.020

17 June 2024

A modified poisson regression approach to prospective studies with binary data

36

1 reference

10.1016/J.BBMT.2010.07.020

https://api.crossref.org/works/10.1016/J.BBMT.2010.07.020

17 June 2024

Which donor should be chosen for hematopoietic stem cell transplantation among unrelated HLA-A, -B, and -DRB1 genomically identical volunteers?

38

1 reference

10.1016/J.BBMT.2010.07.020

https://api.crossref.org/works/10.1016/J.BBMT.2010.07.020

17 June 2024

Impact on the cytomegalovirus (CMV) viral load by CMV-specific T-cell immunity in recipients of allogeneic stem cell transplantation.

39

1 reference

10.1016/J.BBMT.2010.07.020

https://api.crossref.org/works/10.1016/J.BBMT.2010.07.020

17 June 2024

Early reactivation of cytomegalovirus and high risk of interstitial pneumonitis following T-depleted BMT for adults with hematological malignancies

40

1 reference

10.1016/J.BBMT.2010.07.020

https://api.crossref.org/works/10.1016/J.BBMT.2010.07.020

17 June 2024

Clonotypic structure of the human CD4+ memory T cell response to cytomegalovirus

42

1 reference

10.1016/J.BBMT.2010.07.020

https://api.crossref.org/works/10.1016/J.BBMT.2010.07.020

17 June 2024

Enumeration of cytomegalovirus-specific interferongamma CD8+ and CD4+ T cells early after allogeneic stem cell transplantation may identify patients at risk of active cytomegalovirus infection

43

1 reference

10.1016/J.BBMT.2010.07.020

https://api.crossref.org/works/10.1016/J.BBMT.2010.07.020

17 June 2024

Levels of CMV specific CD4 T cells are dynamic and correlate with CMV viremia after allogeneic stem cell transplantation

44

1 reference

10.1016/J.BBMT.2010.07.020

https://api.crossref.org/works/10.1016/J.BBMT.2010.07.020

17 June 2024

Cytomegalovirus seropositivity adversely influences outcome after T-depleted unrelated donor transplant in patients with chronic myeloid leukaemia: the case for tailored graft-versus-host disease prophylaxis

45

1 reference

10.1016/J.BBMT.2010.07.020

https://api.crossref.org/works/10.1016/J.BBMT.2010.07.020

17 June 2024

Pre-emptive treatment of CMV DNAemia in paediatric stem cell transplantation: the impact of recipient and donor CMV serostatus on the incidence of CMV disease and CMV-related mortality

46

1 reference

10.1016/J.BBMT.2010.07.020

https://api.crossref.org/works/10.1016/J.BBMT.2010.07.020

17 June 2024

Patient cytomegalovirus seropositivity with or without reactivation is the most important prognostic factor for survival and treatment-related mortality in stem cell transplantation from unrelated donors using pretransplant in vivo T-cell depletion

47

1 reference

10.1016/J.BBMT.2010.07.020

https://api.crossref.org/works/10.1016/J.BBMT.2010.07.020

17 June 2024

Polyclonal rabbit antithymocyte globulin exhibits consistent immunosuppressive capabilities beyond cell depletion.

48

1 reference

10.1016/J.BBMT.2010.07.020

https://api.crossref.org/works/10.1016/J.BBMT.2010.07.020

17 June 2024

Mechanisms of action of antithymocyte globulin: T-cell depletion and beyond

49

1 reference

10.1016/J.BBMT.2010.07.020

https://api.crossref.org/works/10.1016/J.BBMT.2010.07.020

17 June 2024

Identifiers

10.1016/J.BBMT.2010.07.020

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44554036&oldid=2182014046"